Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical Datasets
Wei, W.-Q.; Yan, C.; Grabowska, M. E.; Dickson, A. L.; Li, B.; Wen, Z.; Roden, D. M.; Stein, C. M.; Embi, P. J.; Peterson, J. F.; Feng, Q.; Malin, B. A.
Show abstract
Drug repurposing represents an attractive alternative to the costly and time-consuming process of new drug development, particularly for serious, widespread conditions with limited effective treatments, such as Alzheimers disease (AD). Emerging generative artificial intelligence (GAI) technologies like ChatGPT offer the promise of expediting the review and summary of scientific knowledge. To examine the feasibility of using GAI for identifying drug repurposing candidates, we iteratively tasked ChatGPT with proposing the twenty most promising drugs for repurposing in AD, and tested the top ten for risk of incident AD in exposed and unexposed individuals over age 65 in two large clinical datasets: 1) Vanderbilt University Medical Center and 2) the All of Us Research Program. Among the candidates suggested by ChatGPT, metformin, simvastatin, and losartan were associated with lower AD risk in meta-analysis. These findings suggest GAI technologies can assimilate scientific insights from an extensive Internet-based search space, helping to prioritize drug repurposing candidates and facilitate the treatment of diseases.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease 93%
- Machine Learning Prediction of Incidence of Alzheimers Disease Using Large-Scale Administrative Health Data 93%
- Interpretable deep learning approach for extracting cognitive features from hand-drawn images of intersecting pentagons in older adults 93%
Similar papers in this journal
- Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology 95%
- Enhancing Early Detection of Cognitive Decline in the Elderly through Ensemble of NLP Techniques: A Comparative Study Utilizing Large Language Models in Clinical Notes 91%
- Multi-ancestry omic Mendelian randomization revealing putative drug targets of COVID-19 severity 90%
Similar papers in this journal
- Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer’s Disease and Related Dementias 93%
- Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research 90%
- Real-world datasets for the International Registry for Alzheimer’s Disease and Other Dementias (InRAD) and other registries: an international consensus 90%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.